Skip to content

Balchem BCPC Unrealized Gain (Loss) on Foreign Currency Transactions and Deferred Compensation

Unrealized Gain (Loss) on Foreign Currency Transactions and Deferred Compensation at other companies

Constellium logo
ConstelliumCSTM
$43M+491%
Blue Owl Capital logo
Blue Owl CapitalOBDC
-$11.55M-393%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$204K+212%
GOL
Acushnet HoldingsGOLF
-$1.92M-192%
Las Vegas Sands logo
Las Vegas SandsLVS
-$3M-50.0%
KLA Corporation logo
KLA CorporationKLAC
-$2.3M+79.7%

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.33B+0.5%
Enterprise value$5.3B+0.1%
P/E33.7×-5.1×
P/S-0.5×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept bcpc:UnrealizedGainLossOnForeignCurrencyTransactionsAndDeferredCompensation.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation?
Balchem (BCPC) reported unrealized gain (loss) on foreign currency transactions and deferred compensation of -$717K in Q1 2026.
How has Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation changed year-over-year?
Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation decreased by 2887.5% year-over-year, from -$24K to -$717K.
What is the long-term trend for Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation?
Over 3 years (2021 to 2025), Balchem's unrealized gain (loss) on foreign currency transactions and deferred compensation has grown at a 21.0% compound annual growth rate (CAGR), from -$384K to -$680K.
What does unrealized gain (loss) on foreign currency transactions and deferred compensation mean?
This metric represents the non-cash impact of fluctuations in foreign currency exchange rates and changes in the value of deferred compensation liabilities on the company's net income. It adjusts reported earnings to isolate cash-based operating performance from accounting gains or losses that do not involve immediate cash outflows or inflows. Monitoring this helps investors distinguish between core operational profitability and volatility driven by global currency markets or compensation plan revaluations.